Thor Medical ASA (FRA:8NN) Net Margin %: -7,032.35% (As of Dec. 2025)

What is Thor Medical ASA Net Margin %?

Thor Medical ASA FRA:8NN +1.71% 21 Net Margin % is -7,032.35% as of Dec. 2025. GuruFocus rates FRA:8NN with a GF Score™ of 21/100. The stock has 2 warning signs investors should review. Among 946 Biotechnology companies, Thor Medical ASA ranks worse than 93.55% on this metric.

Net margin is calculated as Net Income divided by its Revenue. Thor Medical ASA's Net Income for the six months ended in Dec. 2025 was €-2.39 Mil. Thor Medical ASA's Revenue for the six months ended in Dec. 2025 was €0.03 Mil. Therefore, Thor Medical ASA's net margin for the quarter that ended in Dec. 2025 was -7,032.35%.

The historical rank and industry rank for Thor Medical ASA's Net Margin % or its related term are showing as below:

FRA:8NN' s Net Margin % Range Over the Past 10 Years
Min: -97289.4 Med: -75003.18 Max: -11600
Current: -11600

FRA:8NN's Net Margin % is ranked worse than
93.55% of 946 companies
in the Biotechnology industry
Industry Median: -88.815 vs FRA:8NN: -11600.00

Thor Medical ASA (FRA:8NN) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Thor Medical ASA Net Margin % Related Terms

Thor Medical ASA Net Margin % Historical Data

* Premium members only.

The historical data trend for Thor Medical ASA's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Thor Medical ASA Net Margin % Chart

Thor Medical ASA Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Net Margin %

Get a 7-Day Free Trial

0.00

-13,248.65

Thor Medical ASA Semi-Annual Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24	Jun25	Dec25
Net Margin %	Get a 7-Day Free Trial															0.00	0.00	0.00	-28,466.67	-7,032.35

FRA:8NN vs VRTX, REGN, ALNY: Net Margin % Comparison

For the Biotechnology subindustry, Thor Medical ASA's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Thor Medical ASA Net Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Thor Medical ASA's Net Margin % distribution charts can be found below:

* The bar in red indicates where Thor Medical ASA's Net Margin % falls into.

Save Embed

21GF Score

Thor Medical ASA FRA:8NN

Net Margin % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Thor Medical ASA Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Thor Medical ASA's Net Margin for the fiscal year that ended in Dec. 2025 is calculated as

Net Margin	=	Net Income (A: Dec. 2025 )	/	Revenue (A: Dec. 2025 )
	=	-4.902	/	0.037
	=	-13,248.65 %

Thor Medical ASA's Net Margin for the quarter that ended in Dec. 2025 is calculated as

Net Margin	=	Net Income (Q: Dec. 2025 )	/	Revenue (Q: Dec. 2025 )
	=	-2.391	/	0.034
	=	-7,032.35 %

Frequently Asked Questions Learn more about Net Margin % →

What does a Net Margin % of -7,032.35% mean?

Thor Medical ASA (FRA:8NN) has a Net Margin % of -7,032.35% as of Dec. 2025. Net margin is the ratio of total net income to net sales. View historical data on Thor Medical ASA and its competitors. According to the industry distribution chart, Thor Medical ASA ranks #885 out of 946 companies in the Biotechnology industry, placing it in the top 93.6%.

Is Thor Medical ASA's Net Margin % too high?

Thor Medical ASA's current Net Margin % is -7,032.35%. Based on the distribution chart, Thor Medical ASA ranks #885 out of 946 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Thor Medical ASA has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.

How does Thor Medical ASA's Net Margin % compare to VRTX and REGN?

According to the Biotechnology industry distribution chart, Thor Medical ASA ranks #885 out of 946 companies for Net Margin %. This places Thor Medical ASA in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Net Margin % for a Biotechnology company?

A good Net Margin % depends on the Biotechnology industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Net Margin % mean?

A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Thor Medical ASA and its competitors. Thor Medical ASA's current Net Margin % is -7,032.35%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Thor Medical ASA stock overvalued right now?

Thor Medical ASA (FRA:8NN) has a current Net Margin % of -7,032.35%. The current Net Margin % is -7,032.35%. Thor Medical ASA's overall GF Score™ is 21/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Net Margin % calculated?

Net Margin % is calculated from a company's financial statements. For Thor Medical ASA (FRA:8NN), the current Net Margin % is -7,032.35% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Thor Medical ASA Business Description

Industry Healthcare Biotechnology

Comparable Companies OSL:CRNA OSL:AZT OSL:NYKD OSL:LYTIX OSL:ZLNA OSL:SOFTX OSL:ONCIN OSL:EXTX OSL:ABS OSL:ABTEC VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY RVMD ASX:CSL ONC XKRX:068270

Other Exchanges TRMED:Norway 0R6Y:UK

Address Drammensveien 167, Oslo, NOR, 0277

Website https://www.thormedical.com

Thor Medical ASA is a Norway-based biopharmaceutical company. The company is a producer and supplier of alpha-particle emitters for cancer therapy. The production process is based on separation of natural occurring radioactive decay products from thorium. The Company is utilizing alpha-emitters in radiotherapy and cancer treatments using Pb-212, which can be produced from naturally occurring isotope Thorium-232 and Lead-212. It uses a proprietary production process that does not involve irradiation or nuclear reactors to produce alpha-emitting materials. These materials are used by radiopharmaceutical companies in the development of cancer therapies.

21GF Score

Get the complete analysis for FRA:8NN

Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.39

Price

View FRA:8NN Analysis

See Net Margin % data for all stocks →